<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02556034</url>
  </required_header>
  <id_info>
    <org_study_id>CNTO148ART4009</org_study_id>
    <nct_id>NCT02556034</nct_id>
  </id_info>
  <brief_title>Assessment of Tender &amp; Swollen Joints Count Score Performed by a Rheumatologist And Rheumatology Nurses in Patients With RA and PsA.</brief_title>
  <acronym>APRAN</acronym>
  <official_title>Assessment of Tender &amp; Swollen Joints Count Score Performed by a Rheumatologist And Rheumatology Nurses in Patients With Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Isabelle Fortin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Janssen Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre de Rhumatologie de l'Est du Québec</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will establish a comparison in follow-up care of 100 patients between Health Care
      Practitioners, more specifically the rheumatologist and a trained nurse. The study objective
      is to show consistency of evaluation between two different health care professionals, a
      physician and a nurse.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study involves one site in Canada. Patients will complete a self-evaluation of 28 joint
      counts for swelling (SJC) and tenderness (TJC) and assess their disease activity on a Visual
      Analog Scale (VAS). A 28 joint count and VAS will then be assessed by a nurse and by a
      rheumatologist. Clinical Disease Activity Index (CDAI) and Disease Activity Severity 28 - C
      Reactive protein (DAS28-CRP) will be calculated from each data set.

      The same rheumatologist will examine all patients and two nurses will each randomly assess
      half the total enrolled patients. The nurse will be blinded to the patient's joint count and
      VAS, and similarly, the rheumatologist will be blinded to both the patient and nurse's
      assessments. The setting includes 2 nurses with different educational background: one
      technician and one bachelor.

      The training provided to the nurses in this study allows them to master the basis of the
      physical exam, joint count and history of the rheumatoid patient as well as to learn the
      pertinent laboratory parameters. It is a 14-hour course in which the patient is examined
      through observation, palpation, assessment of mobility and stability and specific movement.
      Diagnostic tools such as the Simplified Disease Activity Index (SDAI), Health Assessment
      Questionnaire Disability Index (HAQ), CDAI and DAS-28 are included in the patient evaluation.

      Each enrolled patient will receive a 5-minute training in joint assessment by the nurse. The
      use of the mannequin for joint assessment of swelling and tenderness will be reviewed.
      Objective signs of disease such as swelling, redness and heat will be explained as well as
      the difference between inflammation and bony swelling, the latter being indicative of
      osteoarthritis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of the nurse CDAI result compared to the rheumatologist CDAI result.</measure>
    <time_frame>6 months</time_frame>
    <description>To validate the accuracy of assessment of RA and PsA disease activity by a nurse trained in joint examination using the CDAI as compared to a rheumatologist's same assessment. The level of agreement between evaluators will be investigated using Cohen's Kappa, a statistic tool useful to the measurement of inter-rater agreement for qualitative traits.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Accuracy of the nurse DAS-28 result compared to the rheumatologist DAS-28 result.</measure>
    <time_frame>6 months</time_frame>
    <description>To validate the accuracy of assessment of RA and PsA disease activity by a nurse trained in joint examination using the DAS-28 as compared to a rheumatologist's same assessment. The level of agreement between evaluators will be investigated using Cohen's Kappa, a statistic tool useful to the measurement of inter-rater agreement for qualitative traits.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of TJC results between 3 raters.</measure>
    <time_frame>6 months</time_frame>
    <description>The TJC results from the patient self-assessment, nurse assessment and physician assessment are compared.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of SJC results between 3 raters.</measure>
    <time_frame>6 months</time_frame>
    <description>The SJC results from the patient self-assessment, nurse assessment and physician assessment are compared.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of VAS results between 3 raters.</measure>
    <time_frame>6 months</time_frame>
    <description>The VAS results from the patient self-assessment, nurse assessment and physician assessment are compared.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of time taken by 3 raters to perform disease assessments.</measure>
    <time_frame>6 months</time_frame>
    <description>To compare the time taken by the rheumatologist, nurse and patient to complete each part of the joint count assessment and the VAS. An ANOVA will be used to verify if a significant difference is present in the assessment time between the different raters.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Psoriatic Arthritis</condition>
  <arm_group>
    <arm_group_label>Disease evaluation</arm_group_label>
    <description>Rheumatoid arthritis evaluations.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Disease evaluation.</intervention_name>
    <description>Patients will complete a self-evaluation of 28 joint counts for swelling and tenderness and assess their disease activity on a Visual Analog Scale. A 28 joint count and VAS will then be assessed by a nurse and by a rheumatologist. The same rheumatologist will examine all patients and two nurses will each randomly assess half the total enrolled patients. The nurse will be blinded to the patient's joint count and VAS, and similarly, the rheumatologist will be blinded to both the patient and nurse's assessments.</description>
    <arm_group_label>Disease evaluation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The target population will be subjects with active Rheumatoid Arthritis or Psoriatic
        Arthritis.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Subject is ≥18 years of age.

          2. Has at least one of the following diagnosis at screening

               -  Subject has a diagnosis of RA as defined by the 1987- revised American College of
                  Rheumatology (ACR)- classification criteria for RA and has disease duration of
                  more than 6 months.

               -  Subject must have a diagnosis of active PsA by Classification Criteria for
                  Psoriatic Arthritis (CASPAR) and has disease duration of more than 6 months.

          3. The subject must be able to provide written informed consent and to complete the study
             questionnaires.

        Exclusion Criteria:

          -  Subject with DIP involvement in PsA

          -  Subject with predominant axial symptoms (spondyloarthropathy)

          -  Subject with fibromyalgia

          -  Subject involved in a concomitant study

          -  Subject currently takes ≥10 mg cortisone daily

          -  Subject has taken opioid analgesics within 12 hours of joint count assessment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>NABIL CHAKER, BIOLOGIST</last_name>
    <role>Study Director</role>
    <affiliation>CENTRE DE RHUMATOLOGIE DE L'EST DU QUEBEC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>ISABELLE FORTIN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CENTRE DE RHUMATOLOGIE DE L'EST DU QUEBEC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>FRÉDÉRIC BANVILLE, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université de Montréal</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>NABIL CHAKER, BIOLOGIST</last_name>
    <phone>418 723 2445</phone>
    <phone_ext>201</phone_ext>
    <email>nabil.chaker@crequebec.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre de Rhumatologie de L'Est Du Quebec</name>
      <address>
        <city>Rimouski</city>
        <state>Quebec</state>
        <zip>G5L 8W1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>NABIL CHAKER, BIOLOGIST</last_name>
      <phone>418 723 2445</phone>
      <phone_ext>201</phone_ext>
      <email>nabil.chaker@crequebec.ca</email>
    </contact>
    <investigator>
      <last_name>ISEBELLE FORTIN, MEDECIN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <results_reference>
    <citation>Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, Combe B, Cutolo M, de Wit M, Dougados M, Emery P, Gibofsky A, Gomez-Reino JJ, Haraoui B, Kalden J, Keystone EC, Kvien TK, McInnes I, Martin-Mola E, Montecucco C, Schoels M, van der Heijde D; T2T Expert Committee. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010 Apr;69(4):631-7. doi: 10.1136/ard.2009.123919. Epub 2010 Mar 9. Erratum in: Ann Rheum Dis. @011 Jul;70(7):1349. van der Heijde, Desirée [corrected to van der Heijde, Désirée]. Ann Rheum Dis. 2011 Aug;70(8):1519.</citation>
    <PMID>20215140</PMID>
  </results_reference>
  <results_reference>
    <citation>Atar D, Birkeland KI, Uhlig T. 'Treat to target': moving targets from hypertension, hyperlipidaemia and diabetes to rheumatoid arthritis. Ann Rheum Dis. 2010 Apr;69(4):629-30. doi: 10.1136/ard.2010.128462.</citation>
    <PMID>20237122</PMID>
  </results_reference>
  <results_reference>
    <citation>Anderson J, Caplan L, Yazdany J, Robbins ML, Neogi T, Michaud K, Saag KG, O'Dell JR, Kazi S. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice. Arthritis Care Res (Hoboken). 2012 May;64(5):640-7. doi: 10.1002/acr.21649. Review.</citation>
    <PMID>22473918</PMID>
  </results_reference>
  <results_reference>
    <citation>Scott IC, Scott DL. Joint counts in inflammatory arthritis. Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-7-12. Epub 2014 Oct 30. Review.</citation>
    <PMID>25365082</PMID>
  </results_reference>
  <results_reference>
    <citation>Radner H, Grisar J, Smolen JS, Stamm T, Aletaha D. Value of self-performed joint counts in rheumatoid arthritis patients near remission. Arthritis Res Ther. 2012 Mar 14;14(2):R61. doi: 10.1186/ar3777.</citation>
    <PMID>22417647</PMID>
  </results_reference>
  <results_reference>
    <citation>Cheung PP, Ruyssen-Witrand A, Gossec L, Paternotte S, Le Bourlout C, Mazieres M, Dougados M. Reliability of patient self-evaluation of swollen and tender joints in rheumatoid arthritis: A comparison study with ultrasonography, physician, and nurse assessments. Arthritis Care Res (Hoboken). 2010 Aug;62(8):1112-9. doi: 10.1002/acr.20178.</citation>
    <PMID>20235213</PMID>
  </results_reference>
  <results_reference>
    <citation>Tillett W, Shaddick G, Korendowych E, de Vries CS, McHugh N. Joint count reliability in psoriatic arthritis observational trials--an unreported problem. Rheumatology (Oxford). 2012 Jul;51(7):1333-4. doi: 10.1093/rheumatology/kes095. Epub 2012 May 4.</citation>
    <PMID>22562935</PMID>
  </results_reference>
  <results_reference>
    <citation>Janta I, Naredo E, Martínez-Estupiñán L, Nieto JC, De la Torre I, Valor L, Estopiñán L, Bello N, Hinojosa M, González CM, López-Longo J, Monteagudo I, Montoro M, Carreño L. Patient self-assessment and physician's assessment of rheumatoid arthritis activity: which is more realistic in remission status? A comparison with ultrasonography. Rheumatology (Oxford). 2013 Dec;52(12):2243-50. doi: 10.1093/rheumatology/ket297. Epub 2013 Sep 17.</citation>
    <PMID>24046468</PMID>
  </results_reference>
  <results_reference>
    <citation>Barton JL, Criswell LA, Kaiser R, Chen YH, Schillinger D. Systematic review and metaanalysis of patient self-report versus trained assessor joint counts in rheumatoid arthritis. J Rheumatol. 2009 Dec;36(12):2635-41. doi: 10.3899/jrheum.090569. Epub 2009 Nov 16. Review.</citation>
    <PMID>19918045</PMID>
  </results_reference>
  <results_reference>
    <citation>Levy G, Cheetham C, Cheatwood A, Burchette R. Validation of patient-reported joint counts in rheumatoid arthritis and the role of training. J Rheumatol. 2007 Jun;34(6):1261-5. Epub 2007 Apr 15.</citation>
    <PMID>17444590</PMID>
  </results_reference>
  <results_reference>
    <citation>Cheung PP, Dougados M, Andre V, Balandraud N, Chalès G, Chary-Valckenaere I, Dernis E, Gill G, Gilson M, Guis S, Mouterde G, Pavy S, Pouyol F, Marhadour T, Richette P, Ruyssen-Witrand A, Soubrier M, Nguyen M, Gossec L. The learning curve of nurses for the assessment of swollen and tender joints in rheumatoid arthritis. Joint Bone Spine. 2014 Mar;81(2):154-9. doi: 10.1016/j.jbspin.2013.06.006. Epub 2013 Aug 6.</citation>
    <PMID>23928236</PMID>
  </results_reference>
  <results_reference>
    <citation>Farragher TM, Lunt M, Plant D, Bunn DK, Barton A, Symmons DP. Benefit of early treatment in inflammatory polyarthritis patients with anti-cyclic citrullinated peptide antibodies versus those without antibodies. Arthritis Care Res (Hoboken). 2010 May;62(5):664-75. doi: 10.1002/acr.20207.</citation>
    <PMID>20461787</PMID>
  </results_reference>
  <results_reference>
    <citation>Pincus T, Segurado OG. Most visits of most patients with rheumatoid arthritis to most rheumatologists do not include a formal quantitative joint count. Ann Rheum Dis. 2006 Jun;65(6):820-2. Epub 2005 Nov 16.</citation>
    <PMID>16291813</PMID>
  </results_reference>
  <results_reference>
    <citation>Cheung PP, Gossec L, Mak A, March L. Reliability of joint count assessment in rheumatoid arthritis: a systematic literature review. Semin Arthritis Rheum. 2014 Jun;43(6):721-9. doi: 10.1016/j.semarthrit.2013.11.003. Epub 2013 Nov 13. Review.</citation>
    <PMID>24332117</PMID>
  </results_reference>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 15, 2015</study_first_submitted>
  <study_first_submitted_qc>September 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2015</study_first_posted>
  <last_update_submitted>September 8, 2017</last_update_submitted>
  <last_update_submitted_qc>September 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Centre de Rhumatologie de l'Est du Québec</investigator_affiliation>
    <investigator_full_name>Isabelle Fortin</investigator_full_name>
    <investigator_title>Rheumatologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Arthritis, Psoriatic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

